Sfg demo software download4/8/2023 Preclinical results of third-generation CARs incorporating both elements have shown superiority concerning longevity and proliferation. Published studies have mostly used second-generation CARs with 4-1BB or CD28 as costimulatory domains. ![]() Chimeric antigen receptor (CAR) T cells spark hope for patients with CD19+ B cell neoplasia, including relapsed or refractory (r/r) acute lymphoblastic leukaemia (ALL) or r/r non-Hodgkin’s lymphoma (NHL).
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |